Pyrogenesis Canada Inc. balance sheet PYRGF

Annual Quarterly

Cash and investments were $12.2 million.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line
FY 2021
Dec 31, 2021
Assets
Cash
12
Cash and investments
12
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PYRGF (OTC)
Fiscal year ends
December 31
Incorporated in
Quebec, Canada
Headquarters
Montreal, Quebec, Canada
SEC filer status
, Emerging growth company
SEC CIK
1743344

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.